Assessment of adverse event following immunization and its co-relates among COVID-19 vaccine recipient in Bundelkhand region of Uttar Pradesh: A cross-sectional study

Authors

DOI:

https://doi.org/10.47203/IJCH.2021.v33i02.027

Keywords:

COVID-19, AEFI, Vaccine, Uttar Pradesh, India

Abstract

Background: The COVID-19 pandemic is a global emergency. AEFIs reporting and assessment should be done with high priority as they could change the benefit-risk profile of the vaccine. Objective: To assess adverse effects after COVID-19 vaccination. Methods: This cross-sectional study conducted among 605 heath functionaries taken part from January 2021 to March 2021. Results: The most common AEFI reported was pain at injection site (51.9%). Gender, previous COVID status and perception before vaccination were significantly associated with AEFI. Conclusion: There was no serious adverse event after vaccination. COVID vaccine has a good safety profile.

Downloads

Download data is not yet available.

Downloads

Published

2021-06-30

How to Cite

1.
Kaushal SK, Patel AK, Yadav M, Kumar N. Assessment of adverse event following immunization and its co-relates among COVID-19 vaccine recipient in Bundelkhand region of Uttar Pradesh: A cross-sectional study. Indian J Community Health [Internet]. 2021 Jun. 30 [cited 2021 Jul. 26];33(2):379-82. Available from: https://iapsmupuk.org/journal/index.php/IJCH/article/view/2202

Issue

Section

Short Article